M12 invests in Gimlet Labs
Funding Provisional 90% confidence first seen
Gimlet Labs raised a $300 million Series B round at a $3 billion valuation, led by Andreessen Horowitz (a16z). The backers included Arm Holdings and Microsoft’s M12 fund, with coverage describing the funding as supporting Gimlet’s disaggregated, multi-chip inference platform (and expansion toward custom hardware and additional serverless/data-center infrastructure capacity). This matters because the investment targets the growing need to route different parts of LLM inference workloads to the most suitable chip hardware types, rather than relying on a single accelerator.
The deal
Gimlet Labs $300 million Series B · announced 4 Sep 2026
Investors Andreessen Horowitz M12 Samsung Ventures
Deal terms as reported in the coverage below.
Decision brief
- What changed
- Gimlet Labs raised a $300 million Series B at a $3 billion valuation for its disaggregated inference platform, according to SiliconANGLE AI. The reported backers included Microsoft’s M12, and the company said the funding will expand serverless infrastructure capacity and support a move into custom hardware.
- Why it matters
- For leaders evaluating AI infrastructure strategy, this financing signals continued investor support for architectures that route different LLM inference tasks to different chip types instead of relying on a single accelerator stack. That matters because, if this model proves operationally effective, it could influence infrastructure sourcing, partner choices, and cost-performance optimization for AI deployment; however, the coverage does not provide performance, margin, or customer adoption data, so any business impact assumptions should be treated cautiously.
- Evidence
- The event is supported by a single SiliconANGLE AI report stating that Gimlet Labs raised $300 million at a $3 billion valuation for its disaggregated inference platform, with funding aimed at serverless capacity expansion and custom hardware. The provided summary also states that M12 participated, but the available coverage list contains only one article, so independent confirmation in the supplied materials is limited.
- What remains uncertain
- The supplied coverage does not verify M12’s strategic role, investment size, board involvement, or any commercial relationship implications for Microsoft. It also leaves open whether Gimlet’s multi-chip inference approach delivers durable performance, cost, or utilization advantages at scale, and whether demand justifies the planned infrastructure expansion.
- Monitor next
- Watch for Gimlet Labs to disclose customer deployments, benchmark results, or named infrastructure partnerships that validate the commercial value of its multi-chip inference platform.
Analytical support, not advice — assumptions and open questions stated above.